MURRAY HILL, N.J.--(BUSINESS WIRE)--July 14, 2004--C. R. Bard,
Inc. (NYSE-BCR) today announced following its July board meeting that
Gail K. Naughton, Ph.D., was elected to its board of directors. Dr.
Naughton is the Dean of the College of Business Administration at San
Diego State University, a position she has held since August 2002.
Prior to joining San Diego State University, Dr. Naughton served
for more than 15 years at Advanced Tissue Sciences, Inc., where she
was the company's co-founder and co-inventor of its core technology.
While there, she held a variety of key management positions, including
president, chief operating officer, chief scientific officer and
"Gail comes to Bard with a unique depth and breadth of industry
knowledge and experience, as well as a distinguished academic career,"
said Bard Chairman and Chief Executive Officer, Timothy M. Ring. "We
will clearly benefit from her insight and guidance as a board member,
and I look forward to working with her."
Dr. Naughton earned a Bachelor of Science degree from St. Francis
College, Brooklyn, New York, and both a Master's degree in Histology
and a Ph.D. in Hematology from New York University Medical Center. She
also holds a Master's of Business Administration in Executive
Management from the Anderson School at the University of California,
Los Angeles. Dr. Naughton serves on the boards of several academic
institutions, non-profit organizations and foundations. She has
conducted extensive research, authored numerous scientific
publications and holds more than 75 U.S. and foreign patents.
C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill,
N.J., is a leading multinational developer, manufacturer and marketer
of innovative, life-enhancing medical technologies in the fields of
vascular, urology, oncology and surgical specialty products.
CONTACT: For: C. R. Bard, Inc.
Eric J. Shick, 908-277-8413
Holly P. Glass, 703-754-2848
SOURCE: C. R. Bard, Inc.